BioMarin Pharmaceutical Inc. buy klostergang
Start price
22.05.19
/
50%
€77.94
Target price
04.11.21
€117.79
Performance (%)
-11.88%
End price
17.06.21
€68.68
Summary
This prediction ended on 17.06.21 with a price of €68.68. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.88%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.819% | 0.819% | -2.309% | 27.736% |
| iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
| iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
| iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
| iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
Comments by klostergang for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
Biomarin with a promising pipeline...
including a key upcoming catalyst is three-year data on hemophilia A gene therapy BMN 270 (valoctocogene roxaparvovec), to be announced on June 7.
Kursziel geändert auf 117,789
Stopped prediction by klostergang for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€114.81
18.06.15
18.06.15
€130.00
13.07.15
13.07.15
13.38%
13.07.15
13.07.15
